Cargando…
Beyond neutralization for BNT162b2 mRNA vaccination
Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous expo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279510/ https://www.ncbi.nlm.nih.gov/pubmed/34265240 http://dx.doi.org/10.1016/j.chom.2021.06.013 |
| _version_ | 1783722471595180032 |
|---|---|
| author | Damani-Yokota, Payal Yeung, Stephen T. Khanna, Kamal M. |
| author_facet | Damani-Yokota, Payal Yeung, Stephen T. Khanna, Kamal M. |
| author_sort | Damani-Yokota, Payal |
| collection | PubMed |
| description | Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2. |
| format | Online Article Text |
| id | pubmed-8279510 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82795102021-07-20 Beyond neutralization for BNT162b2 mRNA vaccination Damani-Yokota, Payal Yeung, Stephen T. Khanna, Kamal M. Cell Host Microbe Preview Mounting a robust immune response against SARS-CoV-2 requires neutralization as well as effector T cell functions. In this issue of Cell Host Microbe, Tauzin et al. characterize the humoral and T cell responses after a single dose of BNT162b2 mRNA vaccine in individuals with or without previous exposure to SARS-CoV-2. Elsevier Inc. 2021-07-14 2021-07-14 /pmc/articles/PMC8279510/ /pubmed/34265240 http://dx.doi.org/10.1016/j.chom.2021.06.013 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Preview Damani-Yokota, Payal Yeung, Stephen T. Khanna, Kamal M. Beyond neutralization for BNT162b2 mRNA vaccination |
| title | Beyond neutralization for BNT162b2 mRNA vaccination |
| title_full | Beyond neutralization for BNT162b2 mRNA vaccination |
| title_fullStr | Beyond neutralization for BNT162b2 mRNA vaccination |
| title_full_unstemmed | Beyond neutralization for BNT162b2 mRNA vaccination |
| title_short | Beyond neutralization for BNT162b2 mRNA vaccination |
| title_sort | beyond neutralization for bnt162b2 mrna vaccination |
| topic | Preview |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279510/ https://www.ncbi.nlm.nih.gov/pubmed/34265240 http://dx.doi.org/10.1016/j.chom.2021.06.013 |
| work_keys_str_mv | AT damaniyokotapayal beyondneutralizationforbnt162b2mrnavaccination AT yeungstephent beyondneutralizationforbnt162b2mrnavaccination AT khannakamalm beyondneutralizationforbnt162b2mrnavaccination |